FastCONTROL™ p2RVc-LacZ/ eGFP – Retroviral Dual Reporter

FastCONTROL™ p2RVc-LacZ/ eGFP – Retroviral Dual Reporter

Catalog Number:
RV01268583CAN
Mfr. No.:
PC0129; PC0129-Plus
Price:
$406
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • FastCONTROL™ Dual Reporters are fast, convenient and flexible target cell transfection control ideal for high co-expression of two reporter genes drive for ubiquitous, strong and constitutive promoters. FastCONTROL™ p2RVc-LacZ/ eGFP Dual Reporter is a Retroviral vector that contains cytomegalovirus promoter (Pcmv) to drive the expression of both beta galactosidase (LacZ gene) and green fluorescent protein from Aequoria victoria (eGFP). This is a self-inactivating (SIN) Retroviral vector that lack viral promoter and enhancer activity in their 3′ long terminal repeat (LTR). Quote request

          Includes:
          – 15 µL FastCONTROL™ Dual Reporter (1 µg/µL)
          Plus Version – Includes:
          – 15 µL FastCONTROL™ Dual Reporter (1 µg/µL)
          – 0. 2 mL CANFAST™ Transfection Reagent (1 mg/mL)
          – 15 μL pASSEMBLE™ Viral Packaging Vector (1 μg/ μL)æ

          Please contact us at for specific academic pricing.

          More Details

      • Properties
        • Categories
          Retroviral Plasmids
          Storage
          FastCONTROL™ Dual Reporter Plasmid (-20 °C) and CANFAST™ (4 °C).

          * This product is developed, designed and sold exclusively for Research purposes and in vitro use only (RUO). The product was not tested for use in diagnostics or for drug development, nor is it suitable for administration to humans or animals.

      • Applications
        • Application Description
          Control for assessing the efficiency of transfection in mammalian cells.
          Targering of different cell locations.
          Obtention of cell lines with reporter proteins.

    Documents

    Brochure

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.